Articles tagged with: covid19vaccines

21December

Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.

Hyris presented its new, disruptive T-Cell test at the international conference

On December 17th 2021 Hyris presented its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which addressed strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2.

Posted in Products

Newsletter

Subscribe our newsletter for periodical updates about Hyris solutions.

Address


Headquarter

London

Lower Ground Floor
One George Yard
EC3V 9DF - London, UK
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Center

Milan

C.so Garibaldi 60
Milano 20121, Italy
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Hyris APAC - R&D Center of Excellence

Singapore

38 19 Cecil Street #04-01
The Quadrant at Cecil
Singapore (049704)
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

US West Coast Sales Inquiries

Los Gatos

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Social